We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.62 | -1.64% | 97.44 | 98.22 | 97.44 | 97.76 | 1,562,845 | 21:20:33 |
From Apr 2019 to Apr 2024
By Giulia Petroni
Novartis AG (NOVN.EB) said Monday that its subsidiary Medusa Merger Corp. has successfully completed the tender offer for all outstanding shares of Medicines Co. (MDCO) for a price of $85 a share.
The Swiss drug giant said that the offer ended on Jan.3 and approximately 75% of the outstanding shares of the Medicines Co.'s common stock were validly tendered and not withdrawn, with roughly an additional 16.9% being offered.
As a result of the merger, The Medicines Company's stock will cease to be traded on the Nasdaq, according to Novartis.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
January 06, 2020 01:41 ET (06:41 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
